Evotec and Novo Nordisk enter alliance for obesity, diabetes drug development

Evotec and Novo Nordisk have formed an alliance to further develop small molecule therapies to treat patients suffering from diabetes and obesity. https://www.outsourcing-pharma.com/Article/2018/08/23/Evotec-and-Novo-Nordisk-enter-alliance-for-obesity-diabetes-drug-development